These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 20238101)

  • 1. The need for a transparent, ethical, and successful relationship between academic scientists and the pharmaceutical industry: a view of the Group for the Respect of Ethics and Excellence in Science (GREES).
    Bruyere O; Kanis JA; Ibar-Abadie ME; Alsayed N; Brandi ML; Burlet N; Cahall DL; Chines A; Devogelaer JP; Dere W; Goel N; Hughes N; Kaufman JM; Korte S; Mitlak BH; Niese D; Rizzoli R; Rovati LC; Reginster JY
    Osteoporos Int; 2010 May; 21(5):713-22. PubMed ID: 20238101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conflicts of interest, authorship, and disclosures in industry-related scientific publications: the tort bar and editorial oversight of medical journals.
    Hirsch LJ
    Mayo Clin Proc; 2009 Sep; 84(9):811-21. PubMed ID: 19720779
    [No Abstract]   [Full Text] [Related]  

  • 3. Guidelines for interactions between clinical faculty and the pharmaceutical industry: one medical school's approach.
    Coleman DL; Kazdin AE; Miller LA; Morrow JS; Udelsman R
    Acad Med; 2006 Feb; 81(2):154-60. PubMed ID: 16436576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation next: a hope for ethics? In era of conflicts of interest, signs of progress center on impressionable youth.
    Sloane T
    Mod Healthc; 2008 May; 38(18):23. PubMed ID: 18557480
    [No Abstract]   [Full Text] [Related]  

  • 5. The relationship between paediatricians and commerce.
    Hilliard T; Chambers T
    Paediatr Respir Rev; 2006 Mar; 7(1):54-9. PubMed ID: 16473818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transparent collaboration between industry and academia can serve unmet patient need and contribute to reproductive public health.
    D'Hooghe T
    Hum Reprod; 2017 Aug; 32(8):1549-1555. PubMed ID: 28854594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The corporate coauthor.
    Fugh-Berman A
    J Gen Intern Med; 2005 Jun; 20(6):546-8. PubMed ID: 15987332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacists and industry: guidelines for ethical interactions.
    ; Hatton RC; Chavez ML; Jackson E; Maurey J; Barriere SL; Couchenour R; Evens RP; Gunning K; Hume AL; Hutchison LC; Matzke GR; Noviasky JA; Rospond RM; Kelloway JS; Stevenson JG; Vanderveen RP; Verme-Gibboney CN; Walters D
    Pharmacotherapy; 2008 Mar; 28(3):410-20. PubMed ID: 18294122
    [No Abstract]   [Full Text] [Related]  

  • 9. Conflicts of interest and disclosure in the American Psychiatric Association's Clinical Practice Guidelines.
    Cosgrove L; Bursztajn HJ; Krimsky S; Anaya M; Walker J
    Psychother Psychosom; 2009; 78(4):228-32. PubMed ID: 19401623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ethics issues in academic-industry relationships in the life sciences: the continuing debate.
    Blumenthal D
    Acad Med; 1996 Dec; 71(12):1291-6. PubMed ID: 9114886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The updated AMSA scorecard of conflict-of-interest policies: a survey of U.S. medical schools.
    Carlat DJ; Fagrelius T; Ramachandran R; Ross JS; Bergh S
    BMC Med Educ; 2016 Aug; 16(1):202. PubMed ID: 27519253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transparency and trust.
    Compston JE
    Osteoporos Int; 2010 May; 21(5):711-2. PubMed ID: 20238100
    [No Abstract]   [Full Text] [Related]  

  • 13. Ghostwriting in medical literature.
    Int J Occup Environ Health; 2011; 17(2):168-77. PubMed ID: 21618949
    [No Abstract]   [Full Text] [Related]  

  • 14. A perspective on commercial relationships between ophthalmology and industry.
    Jampol LM; Packer S; Mills RP; Day SH; Lichter PR;
    Arch Ophthalmol; 2009 Sep; 127(9):1194-202. PubMed ID: 19752430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Do gifts from the pharmaceutical industry affect trust in physicians?
    Green MJ; Masters R; James B; Simmons B; Lehman E
    Fam Med; 2012 May; 44(5):325-31. PubMed ID: 23027114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ethical issues at the university-industry interface: a way forward?
    Evans GR; Packham DE
    Sci Eng Ethics; 2003 Jan; 9(1):3-16. PubMed ID: 12645225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug reps off campus! Promoting professional purity by suppressing commercial speech.
    Stell LK
    J Law Med Ethics; 2009; 37(3):431-43, 395. PubMed ID: 19723254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conflicts of interest: a review of institutional policy in Australian medical schools.
    Mason PR; Tattersall MH
    Med J Aust; 2011 Feb; 194(3):121-5. PubMed ID: 21299485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The ethics of the medical-pharmaceutical relationship.
    Vashi NA; Latkowski JA
    Clin Dermatol; 2012; 30(2):188-91. PubMed ID: 22330662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uneasy alliance--clinical investigators and the pharmaceutical industry.
    Bodenheimer T
    N Engl J Med; 2000 May; 342(20):1539-44. PubMed ID: 10816196
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.